Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3))

Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3)) is an IgG1 monoclonal antibody targeting αvβ3 integrin. It inhibits angiogenesis and melanoma tumor growth and can be used to research anticancer. MW :144.18 KD.

Trivial name LM 609
Catalog Number A2991
CAS# 892553-42-3
Size 1mg
Supplier Page http://www.selleckchem.com/products/etaracizumab-anti-integrin-avb3-itgav--itgb3.html